SCHEMBL17851900

SCHEMBL17851900

CC1(C)c2ccc(-c3ccc4oc5ccc(-c6c7ccccc7c(-c7cccc8c7ccc7ccccc78)c7ccccc67)cc5c4c3)cc2-c2ccc3ccccc3c21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.33
ALDH1A1 P00352 8/20 0.33
MAPT P10636 4/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
ESR1 P03372 1/20 0.32
POLB P06746 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAOB P27338 1/20 0.32
HPGD P15428 4/20 0.32
GLA P06280 3/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17851904 0.96 ALDH1A1 (0.33) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851921 0.94 KDM4E (0.31) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851916 0.94 KDM4E (0.33) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851908 0.94 KDM4E (0.34) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851923 0.94 KDM4E (0.35) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851910 0.93 KDM4E (0.31) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851888 0.92 PIM1 (0.33) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851920 0.92 KDM4E (0.36) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851911 0.91 KDM4E (0.32) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL17851897 0.91 HSP90AA1 (0.33) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181542-A1 ANTHRACENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME L1CAM, H1-10, H1-0 KDM4E 1674/4885ALDH1A1 605/4885MAPT 4639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.